Celldex Therapeutics , Inc. (NASDAQ:CLDX), with a market capitalization of $1.72 billion, is a biopharmaceutical company focused on developing innovative therapies for challenging diseases, with its ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.94 billion, finds itself at a critical juncture as it navigates challenges to its flagship Eylea franchise while ...

This is the metadata section. Skip to content viewer section. ‘A Geostrategic SWOT Analysis for Australia’, Centre of Gravity series, no. 49 (Canberra: Strategic and Defence Studies Centre, ANU, June ...